After treating with IL-17A, the expression of MMP2 and MMP9 proteins in cervical cancer cell lines (C33A and Caski) was increased, meanwhile the expression of TIMP-1 and TIMP-2 proteins was decreased(Fig. 2B and C). The gene discussed is MMP2; the disease is cervical cancer.